BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27262708)

  • 21. [Squamous cell carcinoma].
    Yamazaki N
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1392-7. PubMed ID: 17033226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update of the Management of Cutaneous Squamous-cell Carcinoma.
    Maubec E
    Acta Derm Venereol; 2020 Jun; 100(11):adv00143. PubMed ID: 32346744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of non-melanoma skin cancer.
    Lazareth V
    Semin Oncol Nurs; 2013 Aug; 29(3):182-94. PubMed ID: 23958216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons.
    Jambusaria-Pahlajani A; Hess SD; Katz KA; Berg D; Schmults CD
    Arch Dermatol; 2010 Nov; 146(11):1225-31. PubMed ID: 21079057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of Basal cell and squamous cell carcinoma.
    Firnhaber JM
    Am Fam Physician; 2012 Jul; 86(2):161-8. PubMed ID: 22962928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonmelanoma skin cancer.
    Dubas LE; Ingraffea A
    Facial Plast Surg Clin North Am; 2013 Feb; 21(1):43-53. PubMed ID: 23369588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eyelid and ocular surface carcinoma: diagnosis and management.
    Yin VT; Merritt HA; Sniegowski M; Esmaeli B
    Clin Dermatol; 2015; 33(2):159-69. PubMed ID: 25704936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous malignancy of the head and neck.
    Mydlarz WK; Weber RS; Kupferman ME
    Surg Oncol Clin N Am; 2015 Jul; 24(3):593-613. PubMed ID: 25979402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk cutaneous squamous cell carcinoma.
    Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas.
    Maher JM; Schmults CD; Murad F; Karia PS; Benson CB; Ruiz ES
    J Am Acad Dermatol; 2020 Apr; 82(4):920-926. PubMed ID: 31689446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of Upstaging, Between Diagnosis and Surgery, and Clinical Management of Metastatic Cutaneous Squamous Cell Carcinoma: A Case-Control Study.
    Costello CM; Cumsky HJL; Severson KJ; Mi L; DiCaudo DJ; Ochoa SA; Baum CL; Mangold AR
    Dermatol Surg; 2022 Jan; 48(1):12-16. PubMed ID: 34904573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines.
    Mellerio JE; Robertson SJ; Bernardis C; Diem A; Fine JD; George R; Goldberg D; Halmos GB; Harries M; Jonkman MF; Lucky A; Martinez AE; Maubec E; Morris S; Murrell DF; Palisson F; Pillay EI; Robson A; Salas-Alanis JC; McGrath JA
    Br J Dermatol; 2016 Jan; 174(1):56-67. PubMed ID: 26302137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of advanced cutaneous squamous cell carcinoma: a Mohs surgery and dermatologic oncology perspective.
    Wilmas KM; Nguyen QB; Patel J; Silapunt S; Migden MR
    Future Oncol; 2021 Dec; 17(35):4971-4982. PubMed ID: 34608809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revised Mohs surgery care guidelines for squamous cell carcinoma in-situ are overdue.
    Carley SK; Dixon A; Zachary CB; Steinman HK
    Dermatol Online J; 2019 Mar; 25(3):. PubMed ID: 30982299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment recommendations in patients diagnosed with high-risk cutaneous squamous cell carcinoma.
    Veness MJ
    Australas Radiol; 2005 Oct; 49(5):365-76. PubMed ID: 16174174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma.
    Zelin E; Zalaudek I; Agozzino M; Dianzani C; Dri A; Di Meo N; Giuffrida R; Marangi GF; Neagu N; Persichetti P; Toffoli L; Conforti C
    Curr Treat Options Oncol; 2021 Mar; 22(4):35. PubMed ID: 33725197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal and squamous cell carcinomas. What every primary care physician should know.
    Marghoob AA
    Postgrad Med; 1997 Aug; 102(2):139-42, 146, 152-4 passim. PubMed ID: 9270706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic Therapies for Advanced Basal Cell and Cutaneous Squamous Cell Carcinomas: Novel Targeted Therapies and Immunotherapies.
    Krišto M; Šitum M; Čeović R
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):80-92. PubMed ID: 32876033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review.
    Cheng J; Yan S
    J Cutan Pathol; 2016 Nov; 43(11):994-1004. PubMed ID: 27404896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.